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ABSTRACT
Three  new  carotenoids,  cryptocapsin-5,6-epoxide,  3ʹ-deoxycapsanthin-5,6-epoxide,  and 
cryptocapsin-5,8-epoxides, have been isolated from the ripe fruits of red mamey (Pouteria  
sapota).  Cryptocapsin-5,6-epoxide  was  prepared  by  partial  synthesis  via epoxidation  of 
cryptocapsin  and  the  (5R,6S)-  and  (5S,6R)-stereoisomers  were  identified  by  HPLC-ECD 
analysis. Spectroscopic data of the natural (anti) and semisynthetic (syn) derivatives obtained 
by acid-catalyzed rearrangement of cryptocapsin-5,8-epoxide stereoisomers were compared 
for structural elucidation. Chiral HPLC separation of natural and semisynthetic samples of 
cryptocapsin-5,8-epoxides was performed and HPLC-ECD analysis allowed configurational 
assignment of the separated stereoisomers.
Carotenoids  containing  a  -end  group  such  as  capsanthin  (1),  capsorubin  (2),  and 
cryptocapsin (3) occur mainly in red paprika (Capsicum annuum).1-3 Capsanthin (1) has also 
been found in the pollen anthers of Lilium tigrinum,4,5  in the fruit of Berberis spp.,6 as well as 
Asparagus  officinalis.7,8 Capsorubin  (2)  has  also  been  isolated  from  the  integument  of 
Encephalartos altensteinil, petals of Cajophora lateritia,9 and the fruits of A. officinalis.7,8
Earlier we reported the isolation and characterization of a range of carotenoids with a -end 
group from red paprika including capsanthin-5,6-epoxide,10 capsanthin-3,6-epoxide,10,11 5,6-
diepicapsokarpoxanthin,5,12 and capsoneoxanthin,13 which contained 5,6-epoxy-, 3,6-epoxy-, 
3,5,6-trihydroxy- and allenic end groups, respectively. While the  -ring is hydroxylated in 
these carotenoids, Maoka and his co-workers14 have identified two carotenoids with a non-
hydroxylated  -ring from red paprika. A survey of local plants in Panama has revealed the 
presence  of  ketocarotenoids  in  a  range  of  species.  Plants  with  high  concentrations  of 
ketocarotenoids have been reported in fruits such as 'mamey'  (Pouteria sapota), 'maracuya 
chino' (Cionosicyos macranthus), 'jipijapa' (Carludovica palmata), and in young red-brown 
leaves and red seeds of Zamia dressleri.15
We  have  reported  the  isolation  of  sapotexanthin  [(5R)-,-caroten-6-one,  (4)],16 3ʹ-
deoxycapsorubin,  and 3,3ʹ-dideoxycapsorubin,17 from the panamian fruit mamey (Pouteria  
sapota),  which  are  carotenoids  with  non-hydroxylated  -end  groups.  The  structural 
elucidation  of  these  carotenoids  was  accomplished  by  MS,  electronic  circular  dichroism 
(ECD), and NMR methods.16,17 It was also established that the mamey fruit contains several 
carotenoids  with  a  -end  group  including  cryptocapsin  (3)  as  the  main  carotenoid 
component.18
Herein,  the  isolation  of  the  new  carotenoids  cryptocapsin-5,6-epoxide  (5),  3ʹ-
deoxycapsanthin-5,6-epoxide (6), and cryptocapsin-5,8-epoxides (11, 12) is reported from the 
fruits  of  red  mamey.  Cryptocapsin-5,6-epoxide  (5)  was  prepared  by  the  epoxidation  of 
cryptocapsin  (3)  as  a  reference  compound.  Spectroscopic  data  of  natural  (anti,  5)  and 
semisynthetic (syn, 7) compounds were analyzed for structural elucidation.  
RESULTS AND DISCUSSION
Red  mamey  was  extracted  according  to  published  procedures.16 Repeated  column 
chromatography of the mamey extract on Al2O3 and CaCO3 yielded 8 mg cryptocapsin (3), 4 
mg  cryptocapsin-5,6-epoxide  (5),  0.5  mg  3ʹ-deoxycapsanthin-5,6-epoxide  (6),  0.5  mg  -
cryptoxanthin-5,6,5ʹ,6ʹ-diepoxide (8), and 1.5 mg of an epimeric mixture of cryptocapsin-5,8-
epoxides (11, 12).
Structure Elucidation of the Natural Cryptocapsin-5,6-epoxide (5)
The structure of  cryptocapsin-5,6-epoxide (5) was established from its UV-VIS, ECD, MS, 
and 1H  and 13C-NMR  data. The UV-VIS spectrum (max: 480 and 505sh nm in benzene) was 
in agreement with a decaene chromophore containing a conjugated carbonyl group. Reduction 
of  cryptocapsin-5,6-epoxide  (5) with  NaBH4 gave  an  approximately  1:1  mixture  of  the 
corresponding stereoisomeric alcohols. The UV-VIS spectrum of this mixture exhibited well-
defined fine structure and a hypsochromic shift (max: 426, 451, 481 nm in benzene). Upon 
treatment with HCl/HOAc, the 464, 486 nm max value of the resultant product  indicated the 
presence of a 5,6-epoxy group. The HPLC-MS and HRESITOFMS of 5 showed a molecular 
ion  at  m/z  584.4241,  which  corresponds  to  the  formula  C40H56O3.  Owing  to  the  rapid 
rearrangement  of  the 5,6-epoxy to the 5,8-epoxy group during NMR experiments,  1H,1H-
COSY and 13C NMR data could not be recorded.  Thus, NMR analysis was restricted to the 
protons of the end-groups in 5. The 1H NMR chemical shifts of 5 were compared with those 
of  semisynthetic-cryptoxanthin-5ʹ,6ʹ-epoxide19 (9)  and  capsanthin-5,6-epoxide20 (10).  1H 
NMR experiments of 5 revealed the presence of a 5,6-epoxy- end group, a 3-hydroxy-6-oxo-
 end group, and an all-E polyene chain.  Because the NMR data of the syn and anti epoxides 
are  identical,  the  assignments  are  only  given  for  the  semisynthetic  compound.  Since the 
diastereomers with non-hydroxylated (5R,6S) or (5S,6R)-5,6-epoxy-end groups cannot be 
distinguished by their  1H NMR spectra, the configurational assignment of the cyclohexane 
ring was based on chiroptical data. 
The ECD spectra of carotenoid-5,6-epoxides are governed by the configuration of C-5 and C-
6, and additional substituents of the  -end group have no significant influence on the ECD 
transitions. The influence of the additional  -end group on the ECD spectra is also rather 
small,  and hence  the  absolute  configuration  of  the  5,6-epoxy group could  be determined 
unambiguously.21 The natural cryptocapsin 5,6-epoxide (5) gave positive Cotton effects (CEs) 
at 207, 242 and 349 nm and negative ones at 215 and 281 nm, which is in agreement with the 
ECD  data  of  natural  capsanthin-(3S,5R,6S)-5,6-epoxide  (10).20 Consequently,  the  ECD 
spectra confirmed the  (5R,6S)  configuration of natural cryptocapsin-5,6-epoxide (5) (Figure 
1).
Epoxidation of Cryptocapsin (3)
In order  to  characterize  the natural  cryptocapsin-5,6-epoxide (5),  it  was  synthesized  from 
cryptocapsin (3) by epoxidation with monoperoxophthalic  acid.  The epoxidation produced 
two diastereomeric 5,6-epoxides with (5R,6S)  and (5S,6R) absolute configurations.19,20 The 
separation of such diasteromeric epoxides with unsubstituted -ring is usually not considered 
straightforward.  However,  in  our  case,  base-line  separation  of  (5R,6S)-  and  (5S,6R)-
cryptocapsin-5,6-epoxide diastereomers (5 and  7, respectively) was achieved on a Chiralcel 
OD HPLC column, which showed ca. equal amounts of the two diasteromers (Figure 2).
The OR-detected HPLC chromatogram showed that both diastereomers had positive optical 
rotation and hence this optical parameter was not suitable to distinguish them.  Since online 
HPLC-ECD  measurements  had  been  shown  an  efficient  tool  for  studying  stereoisomeric 
mixtures of natural products,22-24 this technique was employed in separation of diastereomers 5 
and 7. The HPLC-ECD chromatogram (Figure 2a, upper curve) recorded at 280 nm showed 
opposite  CEs  for  the  two  diastereomers.  Online  HPLC-ECD  spectra  were  recorded  by 
stopping the flow of the eluent in the HPLC-ECD flow cell at the maximum concentration of 
the separated diastereomers. The diastereomers had near mirror image ECD curves above 250 
nm allowing the configurational assignment of the synthetic diastereomers (Figure 3).
The  CEs  of  natural  (anti,  5)  and  semisynthetic  (syn,  7)  cryptocapsin  5,6-epoxides  had 
opposite  signs  above  250  nm reflecting  the  different  configuration  of  the  5,6-epoxy-end 
groups.  These  data  corroborated  well  the  reported  values  of  anti and  syn-capsanthin-5,6-
epoxide.20 1D and 2D NMR analysis was also performed for the diastereomeric mixture of 
(5R,6S)-  and  (5S,6R)-cryptocapsin-5,6-epoxides  5 and  7.  The  1H  and  13C  signals  were 
assigned by means of 2D 1H COSY, 13C HSQC and 13C HMBC spectra. The proton chemical 
shifts  of the end groups (H-7 at   5.90 ppm,  H-8 at   6.29 ppm) and the  3JH,H coupling 
constants (J7,8  = 15.4 Hz) were identical with the corresponding data of the natural (5R,6S) 
cryptocapsin-5,6-epoxide (5). HSQC experiments revealed the presence of 5,6-epoxy- and 3-
hydroxy-6-oxo- end groups, since H-3ʹ resonated at 4.51 ppm as a multiplet and C-3ʹ at 70.4 
ppm.25
Structure Elucidation of 3ʹ-Deoxycapsanthin-5,6-epoxide (6)
The  3ʹ-deoxycapsanthin-5,6-epoxide  (6)  showed  a  similar  UV-VIS  spectrum  to  that  of 
cryptocapsin-5,6-epoxide (5) [max: 480 and 505(sh) nm in benzene, which is shifted to 464, 
486 nm after acid treatment in benzene]. The HRESITOFMS exhibited a parent ion at  m/z 
584.4232, which corresponded to the formula C40H56O3. Owing to the small amount of sample 
available, this compound was characterized only by 1H NMR. 1H chemical shifts of the end 
groups and  3JH,H coupling constants were compared with those of sapotexanthin16 (4)  and 
capsanthin-5,6-epoxide (10),20 confirming the proposed structure. The proton signal at  3.93 
and 3JH,H values of the 3-hydroxy--end group were identical with the corresponding literature 
data.19,20 These  data  indicated  that  the  hydroxy group is  attached  to  the cyclohexane ring 
(3.93 for H-3).25 The 1H signals of the 14 olefinic protons were only partially assigned. The 
ECD spectrum of 3´-deoxycapsanthin-5,6-epoxide (6) showed positive CEs at 240 and 347 
nm and negative ones at 214 and 280 nm, which were in agreement with the ECD data of 
natural  capsanthin-5,6-epoxide.20 Thus,  the ECD spectrum confirmed the  (5R,6S) absolute 
configuration of  6 (Figure 1). Based on the NMR and ECD data,  6 was identified as (all-
E,3S,5R,6S,5ʹR)-3-hydroxy-,-caroten-6ʹ-one, for which the 3ʹ-deoxycapsanthin-5,6-epoxide 
trivial name is proposed.
Structural Elucidation of -Cryptoxanthin-5,6,5ʹ,6ʹ-diepoxide (8) 
In the UV-VIS spectra  of  8,  the 428, 453, and 483 nm maxima in benzene and the fine 
structures were in accordance with the reported data for -cryptoxanthin-5,6,5ʹ,6ʹ-diepoxide.19 
On acidic  treatment,  8 underwent  furanoid rearrangement  and the rearranged product  had 
characteristic absorption maxima at 388, 410, 436 nm in benzene. The identification of 8 was 
based on comparison with NMR data published by our group for the corresponding 5,6-epoxy 
end groups.19 The ECD spectrum of  8 was similar to that of the reported spectrum,19 hence 
confirming the (3R,5R,6S,5ʹR,6ʹS) absolute configuration (Figure 1).
Structural Elucidation of Cryptocapsin-5,8-epoxides (11, 12)
The UV-VIS spectrum of the mixture of 11 and 12 (max: 464 and 486 nm in benzene) was in 
agreement with a nonaene chromophore containing a conjugated carbonyl group. The HPLC-
MS exhibited a parent ion signal at m/z 584.42, which corresponded to a molecular formula of 
C40H56O3. The HPLC analysis of this compound showed two peaks with identical UV-VIS 
spectra  indicating  the  presence  of  two  stereoisomers  with  (5R,8S)  and  (5R,8R)  absolute 
configuration.  However,  these  stereoisomers  could  not  be  separated  by  column 
chromatography using a CaCO3 stationary phase. The proton chemical shifts and coupling 
constants,  and  13C chemical  shifts  of  the  5,8-epoxy--end  group  were  identical  with  the 
reported data.25,26 Pairs of doublets appearing at 5.16 and 5.24 ppm (H-7) as well as at 5.18 
and 5.08 ppm (H-8) confirmed the presence of the two stereoisomers with ~2 : 1 ratio. The 1H 
and 13C chemical shift values of H-8 and C-7 of the -end group of 11 and 12 were different, 
which suggested different  configuration of C-8.  Owing to their  complexity,  the  13C NMR 
signals of 11 and 12 were only partially assigned and 13C NMR data could not be obtained for 
the quaternary carbons.
The base-line separation  of  11 and  12 was achieved on a Chiralpak IC column.  The UV 
chromatogram showed that the two epoxides had a 1:1.8 ratio (Figure 4).  Since the amount of 
sample  was  not  sufficient  for  multiple  injections  and  online  HPLC-ECD  analysis,  the 
authentic  samples  of  11 and  12 had  to  be  synthesized.  This  was  accomplished  by acid-
catalyzed rearrangement of the stereoisomeric mixture of cryptocapsin-5,6-epoxides 5 and 7, 
which afforded a stereoisomeric mixture of cryptocapsin-5,8-epoxides (11-14). A base-line 
HPLC separation of the resulting four stereoisomeric cryptocapsin-5,8-epoxides (11-14) was 
achieved on a Chiralpak IC column (Figure 4) using the same HPLC conditions that were 
developed for the separation of (5R,8S)-11 and (5R,8R)-12. The HPLC analysis of synthetic 
epoxides showed a 1:2.7:1.1:2.3 ratio of the stereoisomers. Comparison of the HPLC profiles 
of natural and synthetic cryptocapsin-5,8-epoxides permitted the identification of synthetic 
(5R,8S)-11 and (5R,8R)-12 as the the first- and fourth-eluting stereoisomers, respectively. The 
absolute configurations of 11 and 12 were assigned on the basis of their online HPLC-ECD 
spectra. On the basis of reported ECD data of natural (5R,6S)-cryptocapsin 5,6-epoxide (5),27 
the (5R) absolute configuration was assigned for both 11 and 12. Moreover, the onle HPLC-
ECD spectra of 11 and 12 showed opposite CEs at 204 and 267 nm, which suggested (5R,8S) 
absolute  configuration  for  the  first-eluting  stereoisomer  [(5R,8S)-11]  and  (5R,8R)  for  the 
fourth-eluting  one  [(5R,8R)-12]  in  accordance  with  the  literature  data  of  furanoid 
derivatives.28 The second-eluting stereoisomers 13 and the third-eluting 14  had (5S) absolute 
configuration, and hence they were identified as  (5S,8R)-13 and (5S,8S)-14 (Fig. 5).
Biosynthesis
The  formation  of  3-hydroxy--end  group  from  a  3-hydroxy-5,6-epoxy--end  group  by 
pinacol rearrangement is a well known biosynthetic route.29 Capsanthin (1), capsorubin (2), 
and cryptocapsin (3) are formed by this transformation from antheraxanthin, violaxanthin, and 
-cryptoxanthin-5,6-epoxide,  respectively.2 Carotenoids  possessing  a  5,6-epoxy  functional 
group in their hydroxylated  -rings are quite common in nature. However, carotenoids with 
5,6-epoxy groups in a non-hydroxylated -ring have been rarely reported. In the red mamey, 
the  presence  of  carotenoids  containing  no  hydroxylated  -rings  can  be  attributed  to  the 
coincidence  of  two  rare  metabolic  events:  1)  high  activity  of  enzymes  catalyzing  the 
epoxidation of non-hydroxylated  -rings and 2) enzyme-catalyzed pinacol rearrangement of 
epoxides.  The  high  concentration  of  -cryptoxanthin-5,6,5ʹ,6ʹ-diepoxide  (8)  that  contains 
hydroxylated  and  non-hydroxylated  5,6-epoxy--rings  facilitates  the  formation  of 
cryptocapsin-5,6-epoxide (5) and 3´-deoxycapsanthin-5,6-epoxide (6) (Scheme 1). 
EXPERIMENTAL SECTION
General Experimental Procedures: The UV-VIS spectra were recorded with a Jasco 
V-530 spectrophotometer in benzene. The exact mass measurements (HRESITOFMS) were 
performed using a Waters Q-TOF Premier mass spectrometer (Waters Corporation, 34 Maple 
St,  Milford,  MA,  USA).  The  sample  was  dissolved  in  MeOH  and  measured  in  positive 
electrospray ionization mode.
The 1H (400 MHz) and 13C NMR (100 MHz) spectra were measured with a Varian UNITY 
INOVA 400-WB spectrometer and on a Bruker DRX Avance II (500/125 MHz for  1H/13C) 
spectrometer. Chemical shifts are referenced to internal TMS (1H), or to the residual solvent 
signals  (13C).  ECD  spectra  were  recorded  at  room  temperature  with  a  J-810 
spectropolarimeter.
HPLC-DAD Analysis: The HPLC system was interfaced into gradient pump Dionex 
P680, equipped with a Dionex PDA-100 detector and the data were processed by Chromeleon 
6.70 software. The HPLC separations were carried out on an endcapped C30 column (250 x 
4.6 mm i.d.; YMC C30, 5µm). The eluents consisted of (A) MeOH : MTBE : H2O = 81 : 15 : 
4 and (B) MeOH : MTBE : H2O = 6 : 90 : 4. The chromatographic separation were carried out 
using a linear gradient consisting of 100% eluent A at time zero that was changed to 50% 
eluent B within 45 minute at a flow rate of 1 mL/min. 
Chiral HPLC and HPLC-ECD Analysis: Chiral HPLC separations were carried out with a 
Jasco HPLC system on Chiralcel OD column (0.46 cm  25 cm, 5 m) using n-hexane:EtOH 
= 1:1 at a flow rate of 0.5 mL/min for 5 and 7 or Chiralcel IC (5 µm, 150  4.6 mm) with n-
hexane:EtOH  =  8:2  at  a  flow  rate  of  1.0  mL/min  for  11-14.  HPLC-UV  and  OR 
chromatograms  were  measured  with  a  Jasco  MD-910  multiwavelength  and  OR-2090Plus 
chiral  detector,  respectively.  The baseline of the chromatograms were zeroed immediately 
after the start of each run; this allowed the measurement of the relative absorbance or optical 
rotation. The HPLC-ECD traces were recorded at the specified wavelength with a Jasco J-810 
ECD spectropolarimeter equipped with a 1 cm path length HPLC flow cell and the baseline 
was  zeroed  after  the  start  of  each  run.  The on-line  ECD and  UV spectra  were  recorded 
simultaneously by stopping the flow at  the UV absorption maximum of each peak.  ECD 
ellipticity values () were not corrected for concentration. For an HPLC-ECD spectrum, three 
consecutive  scans  were  recorded  and  averaged  with  2  nm bandwidth,  1  s  response,  and 
standard sensitivity. The HPLC-ECD spectrum of the eluent was recorded in the same way. 
The concentration of the injected sample was set so that the HT (voltage) value did not exceed 
500 V in the HT channel.
Plant Material.  Matured fruits were purchased from the Metropolitan public market in 
Panama City, Panama.
Extraction  and  Isolation: The  pulp  of  red  mamey  (500  g)  was  homogenized  in  a 
porcelain  mortar  with  50  g  of  NaHCO3 and  extracted  with  acetone  until  the  extract  was 
colorless. The extract was diluted with a mixture of Et2O/n-hexane (1:1), washed with H2O to 
remove acetone, dried over Na2SO4, and evaporated to dryness. The residue was dissolved in 
Et2O and saponified with methanolic KOH. After saponification,  the ethereal solution was 
washed with H2O and evaporated. The residue was subjected to open column chromatography 
(Al2O3 Brokman grade III) using an increasing percentage of Et2O in n-hexane. Cryptocapsin-
5,6-epoxide  (5),  3ʹ-deoxycapsanthin-5,6-epoxide  (6)  cryptoxanthin-5,6,5ʹ,6ʹ-diepoxide  (8), 
and  cryptocapsin-5,8-epoxides  (11,  12)  were  isolated  in  pure  form by additional  column 
chromatography of Fraction 7 that was eluted with 50% Et2O in n-hexane. The purity of the 
compounds was verified by HPLC-DAD.
Fraction  7  was  subjected  to  open  column  chromatography  (CaCO3 Biogal,  Hungary, 
toluene:n-hexane = 30:70). After development five fractions were visible: Fraction 71: 10 mm 
brick  red  band (mixture  of  cryptocapsin-5,8-epoxides  (11,  12)  and  3ʹ-deoxycapsorubin17); 
Fraction 72: 10 mm pink band: cryptocapsin-5,6-epoxide (5);  Fraction 73: 20 mm red band 
cryptocapsin  (3);  Fraction  74:  10 mm pink band 3ʹ-deoxycapsanthin-5,6-epoxide  (6);  and 
Fraction 75:  3 mm yellow band cryptoxanthin-5,6,5ʹ,6ʹ-diepoxide (8). 
After processing that consisted of cutting the column packing into sections and extracting 
each section, Fractions 72-75 were obtained that were crystallized from benzene and n-hexane 
yielding  4  mg  of  cryptocapsin-5,6-epoxide  (5),  8  mg  of  cryptocapsin  (3),  0,5  mg  of  3ʹ-
deoxycapsanthin-5,6-epoxide (6), and 0.5 mg of cryptoxanthin 5,6,5ʹ,6ʹ-diepoxide (8).
The zone  containing  cryptocapsin-5,8-epoxides  (11,  12)  was  subsequently  subjected  to  a 
second  OCC  separation  (CaCO3 Biogal,  Hungary,  4  %  acetone  in  n-hexane).  After 
development, the following fractions were obtained: 5 mm red band (3ʹ-deoxycapsorubin), 7 
mm yellow band (11, 12). After desorption the mixture of cryptocapsin-5,8-epoxides (11, 12) 
was crystallized (benzene-n-hexane 1:10) to give 1.5 mg of red crystals.
Preparation  of  Semisynthetic  Cryptocapsin-5,6-epoxides: To  a  solution  of 
cryptocapsin  acetate  (21  mg)  in  Et2O  (80  mL)  at  room  temperature,  ca. 0.005  M 
monoperoxyphthalic acid in Et2O (5 ml) was added. The mixture was kept under N2, in the 
dark, and after 6 and 10 h, respectively, additional monoperoxyphthalic acid solution (5 and 8 
mL) was added.  After 20 h,  the mixture was washed with  5% aq.  NaHCO3 solution,  the 
organic phase was dried (Na2SO4), and a 30% KOH/MeOH solution (100 mL) was added. 
After 16 h, the solution was washed with H2O until neutral, dried (Na2SO4), and evaporated. 
Crystallization from benzene and n-hexane (ratio 1:10) yielded 5 mg of dark red crystals.
Preparation  of  Cryptocapsin-5,8-epoxides:  To  a  solution  of  3  mg  of  semisynthetic 
cryptocapsin 5,6-epoxide (mixture of 5 and 7) in 50 mL of Et2O,  0.1 mL of HOAc-HCl (9:1) 
solution were added at room temperature. The mixture was kept under N2 in the dark. The 
reaction was monitored by UV-VIS. After  0.5 h,  the mixture  was diluted  with Et2O, and 
washed with 5%  aqueous NaHCO3 solution,  the  Et2O phase was dried over  Na2SO4,  and 
evaporated to dryness. The residue was crystallized from benzene and n-hexane (ratio 1:10), 
yielding 2.5 mg of yellow crystals.
(5R,6S,3ʹS,5ʹR)-Cryptocapsin-5,6-epoxide  ((5R,6S,3ʹS,5ʹR)-3ʹ-hydroxy-5,6-dihydro-
5,6-epoxy-,-caroten-6ʹ-one, 5): red crystals, mp. 136-137 oC, UV-VIS (benzene): max 480 
and 505 (shoulder) nm, max after acid treatment: 464, 486 nm; 1H NMR (400 MHz, CDCl3)  
0.84 (3H, s Me-16ʹ);  0.94 (3H, s Me-16); 1.04 (1H, dd, Hax-2); 1.10 (3H, s, Me-17), 1.15 (3H, 
s Me-18); 1.21 (3H, s Me-17ʹ); 1.37 (3H, s, Me-18ʹ); 1.43 (1H, m, H-3); 1.49 (1H, dd, H ax-4ʹ, 
Jgem  = 14.5 Hz,  J4ʹax,3ʹ  = 3.1 Hz); 1.50 (1H, dd, Heq-2);  1.71 (1H, dd, Hax-2ʹ,  Jgem=13.7 Hz, 
J2ʹax,3ʹ=3.2 Hz); 1.72 (1H, dd, Hax-4); 1.89 (1H, dd, Heq-4); 1.94 (3H, s, Me-19); 1.96 (6H, s 
Me-20,19ʹ); 1.98 (3H, s, Me-20ʹ); 2.00 (1H, dd, Heq-2ʹ,  Jgem  = 13.7 Hz, J2ʹeq,3ʹ  = 7.8 Hz); 2.95 
(1H, dd, Heq-4ʹ,  Jgem  = 14.5 Hz, J4ʹeq,3ʹ  = 8.7 Hz); 4.51 (1H, m, H-3ʹ); 5.90 (1H, d, H-7, J7,8  = 
15.4 Hz); 6.19 (1H, d, H-10, J10,11 = 11.3 Hz); 6.27 (1H, d, H-14); 6.29 (1H, d, J8,7 = 15.4 Hz); 
6.34 (2H, m, H-8, H-14ʹ); 6.37 (1H, d, H-12, J12,11= 14.9 Hz); 6.44 (1H, d, H-7ʹ,  J7ʹ,8ʹ  = 15.1 
Hz);  6.51 (1H, dd, H-12ʹ, J12ʹ,11ʹ = 14.6 Hz); 6.56 (1H, d, H-10ʹ, J10ʹ,11ʹ = 11.4 Hz); 6.61 (1H, d, 
H-11ʹ, J11ʹ,10ʹ = 11.4 Hz); 6.63 (1H, d, H-11, J11,10 = 11.3 Hz); 6.65 (1H, m, H-15); 6.69 (1H, m, 
H-15ʹ); 7.32 (1H, d, H-8ʹ,  J8ʹ,7ʹ  = 15.1 Hz);  ECD n-hexane,  [nm] (): 375 (0.46), 349 
(3.45), 334sh (2.59), 321sh (1.10), 281 (8.05), 271sh (4.47), 242 (3.53), 226sh (1.42), 215 
(5.88); HRESITOFMS: m/z 584.4240 (calcd. for C40H56O3, 584.4229).
Mixture  of  (5R,6S,3ʹS,5ʹR)-Cryptocapsin-5,6-epoxide  (5)  and  (5S,6R,3ʹS,5ʹR)-
Cryptocapsin-5,6-epoxide (7): red crystals, UV-VIS (benzene): max 480 and 505 (shoulder) 
nm, max after acid treatment: 464, 486 nm; 1H NMR (400 MHz, CDCl3):  0.84 (3H, s, Me-
16ʹ); 0.94 (3H, s, Me-17); 1.04 (1H, dd, Hax-2); 1.10 (3H, s, Me-16); 1.15 (3H, s, Me-18); 1.21 
(3H, s, Me-17ʹ); 1.37 (3H, s, Me-18ʹ); 1.43 (1H, m, H-3); 1.49 (1H, dd, Hax-4ʹ, Jgem = 14.5 Hz, 
J4ʹax,3ʹ = 3.1 Hz) 1.50 (1H, dd, Heq-2); 1.70 (1H, dd, Hax-2ʹ, Jgem = 13.7 Hz, J2ʹax,3ʹ = 3.2 Hz); 1.72 
(1H, dd, Hax-4); 1.89 (1H, dd, Heq-4); 1.94 (3H, s, Me-19); 1.96 (3H, s, Me-19ʹ); 1.98 (6H, s, 
Me-20, 20ʹ); 2.00 (1H, dd, Heq-2ʹ, Jgem = 13.7 Hz, J2ʹeq,3ʹ  = 7.8 Hz); 2.95 (1H, dd, Heq-4ʹ, Jgem = 
14.5 Hz, J4ʹeq,3ʹ = 8.7 Hz); 4.51 (1H, m, H-3ʹ); 5.90 (1H, d, H-7, J7,8 = 15.4 Hz), 6.19 (1H, d, H-
10, J10,11 = 11.3 Hz); 6.27 (1H, d, H-14); 6.29 (1H, d, H-8, J8,7 = 15.4 Hz); 6.34 (1H, d, H-14ʹ); 
6.37 (1H, d, H-12,  J12,11  = 14.9 Hz); 6.44 (1H, d, H-7ʹ,  J7ʹ,8ʹ  = 15.1 Hz); 6.51 (1H, d, H-12ʹ, 
J12ʹ,11ʹ = 14.6 Hz), 6.56 (1H, d, H-10ʹ, J10ʹ,11ʹ  = 11.4 Hz); 6.61 (1H, dd, H-11ʹ, J11ʹ,10ʹ  = 11.4 Hz); 
6.63 (1H, d, H-11); 6.65 (1H, m, H-15); 6.69 (1H, m, H-15ʹ); 7.32 (1H, d, H-8ʹ , J7ʹ,8ʹ  = 15.1 
Hz); 13C NMR (100 MHz, CDCl3):  12.7 (C-20); 12.8 (C-20ʹ,19); 13.0 (C-19ʹ); 17.10 (C-3); 
21.1 (C-18); 21.3 (C-18ʹ); 25.1 (C-17ʹ); 25.9 (C-16ʹ,17); 26.0 (C-16); 30.1 (C-4); 33.83 (C-1); 
35.8 (C-2); 44.0 (C-1ʹ); 45.3 (C-4ʹ); 50.9 (C-2ʹ); 58.93 (C-5ʹ); 65.5 (C-5); 70.4 (C-3ʹ); 71.4 (C-
6); 120.90 (C-7ʹ); 124.1 (C-11ʹ); 124.4 (C-7); 125.33 (C-11); 129.8 (C-15); 131.6 (C-15ʹ); 
131. 8 (C-10); 132.5 (C-14); 133.6 (C-9ʹ); 134.9 (C-9); 135.2 (C-14ʹ); 136.0 (C-13); 137.2 (C-
8);  137.5 (C-13ʹ);  137.8 (C-12);  140.7 (C-10ʹ);  141.9 (C-12ʹ);  146.8 (C-8ʹ);  202.9 (C-6ʹ); 
HRESITOFMS:  m/z 584.4246 (calcd. for C40H56O3, 584.4229);  5: tr= 31.0 min;  7: tr= 43.1 
min on Chiralcel OD column (0.46 cm  25 cm, 5 m) with n-hexane/EtOH 1:1 and a flow 
rate 0.5 mL/min.
7:  HPLC-ECD  n-hexane/EtOH 1:1,   [nm] ():  351 (0.91), 321sh (0.34), 282 (3.89), 
268sh (1.81), 251sh (0.63), 231 (2.16), 208 (24.98).
5:  HPLC-ECD  n-hexane/EtOH 1:1,   [nm]  ():  385 (0.15),  353 (1.06),  339sh (0.96), 
324sh (0.47), 283 (2.96), 271sh (1.65), 242 (1.09), 215 (2.45).
3ʹ-Deoxycapsanthin-5,6-epoxide  ((3S,5S,6R,5ʹR)-3-hydroxy-5,6-dihydro-5,6-epoxy-
,-caroten-6ʹ-one, 6): red crystals UV-VIS (benzene): max 481 and 504 (shoulder) nm, max 
after acid treatment: 463, 485 nm; 1H NMR (500 MHz, CDCl3):  0.85 (3H, s, Me-16ʹ); 0.98 
(3H, s, Me-17); 1.11 (3H, s, Me-17ʹ); 1.16 (3H, s, Me-16); 1.19 (3H, s, Me-18); 1.27 (1H, dd, 
Hax-2, J2ax,3 = 10.2 Hz), 1.30 (3H, s Me-18ʹ); 1.50 (1H, dd, Hax-4ʹ), 1.57 (1H, dd, Heq-2ʹ); 1.62 
(1H, ddd, Heq-2, Jgem=14.7 Hz, J2eq.,3 =3.6 Hz, J2eq.,4 =1.7 Hz), 1.65 (1H, dd, Hax-4, Jgem= 14.2 
Hz, J4ax.3 = 8.8 Hz); 1.68 (1H, dd, Hax-2ʹ); 1.70 (1H, m, H-3ʹ); 1.93 (1H, s, Me-19); 1.97 (3H, 
s, Me-19ʹ), 1.98 (6H, s, Me-20, 20ʹ); 2.36 (1H, dd, Heq-4); 2.55 (1H, dd, Heq-4ʹ); 3.93 (1H, m, 
H-3), 5.92 (1H, d, H-7, J7,8 = 15.5 Hz); 6.20 (1H, d, H-10, J10,11 = 11.5 Hz); 6.26 (1H, H-14); 
6.29 (1H, d, H-8, J7,8 = 15.5 Hz); 6.34 (1H, d, H-14ʹ); 6.36 (1H, d, H-12, J11,12 = 13 Hz); 6.48 
(1H, d, H-7ʹ, J7ʹ,8ʹ = 15 Hz); 6.51 (1H, d, H-12ʹ, J11ʹ,12ʹ = 14.5 Hz); 6.57 (1H, d, H-10ʹ, J10ʹ,11ʹ = 
11.3 Hz); 6.59 (1H, dd, H-11); 6.63 (1H, dd, H-11ʹ); 6.64 (1H, m, H-15); 6.67 (1H, m, H-15ʹ);  
7.32 (1H, d, H-C8ʹ,  J7ʹ,8ʹ = 15 Hz); ECD n-hexane,   [nm] (): 365 (0.14), 347 (2.32), 
332sh (1.69), 315sh (0.48), 280 (6.35), 270sh (3.64), 240 (2.52), 233sh (0.78), 214 (4.10). 
HR ESI-TOF MS: m/z 584.4231 (calcd. for C40H56O3, 584.4229).
(3S,5R,6S,5ʹR,6ʹS)--Cryptoxanthin-5,6,5ʹ,6ʹ-diepoxide  ((3S,5R,6S,5ʹR,6ʹS)-3-
hydroxy-5,6,5ʹ,6ʹ-tetrahydro-5,6,5ʹ,6ʹ-diepoxy--caroten-3-ol,  8)  orange  crystals,  mp. 
148-150  oC, UV-VIS (benzene):  max 428, 453, and 483 nm,  max after acid treatment: 388, 
410, 436 nm; 1H NMR (500 MHz, CDCl3):  0.95 (3H, s, Me-16ʹ); 0.98 (3H, s, Me-16); 1.08 
(1H, m, H-2ʹ); 1.11 (3H, s, Me-17ʹ); 1.15 (3H, s, Me-17); 1.16 (3H, s, Me-18ʹ); 1.19 (3H, s, 
Me-18); 1.42 (1H, m, H-3ʹ); 1.47 (1H, m, H-2ʹ); 1.75 (1H, m, H-4ʹ); 1.90 (1H, m, H-4ʹ); 1.94 
(6H, s, Me-19,19ʹ); 1.97 (6H, s, Me-20,20ʹ); 1.26 (1H, m, H-2ax); 1.57 (1H, m, H-2eq); 1.64 
(1H, m, H-4ax); 2.40 (1H, m, H-4eq); 3.92 (1H, m, H-3ax); 5.88 (1H, d, H-7,  J7,8 = 15.4 Hz), 
6.20 (2H, d, H-10,10ʹ); 6.27 (1H, d, H-8); 6.29 (2H, d, H-14,14ʹ); 6.36 (2H, d, H-12,12ʹ, J12,11 
= 15 Hz); 6.60 (2H, d, H-11,11ʹ, J11,10  = 11 Hz), 6.63 (2H, dd, H-15,15ʹ); ECD n-hexane,  
[nm] (): 355 (0.17), 327 (1.57), 312sh (0.81), 266 (10.04), 255sh (4.72), 230 (2.72), 
208 (5.05); HR ESI-TOF MS: m/z 584.4214 (calcd. for C40H56O3, 584.4229).
Mixture  of  (5R,8S,3S,5ʹR)-Cryptocapsin-5,8-epoxide (11)  and (5R,8R,3ʹS,5ʹR)-
Cryptocapsin-5,8-epoxide (12):  orange  crystals,  UV-VIS  (benzene):  max 464,  486  nm; 
HRESITOFMS: m/z 584.4301 (calcd. for C40H56O3, 584.4229). tr= 14.3 min for 11 and 19.0 
min for 12 on Chiralcel IC (5 µm, 150  4.6 mm) with n-hexane/EtOH 8:2 and a flow rate of 
1.0 mL/min.
(5R,8S,3ʹS,5ʹR)-Cryptocapsin-5,8-epoxide ((5R,8S,3ʹS,5ʹR)-3ʹ-hydroxy-5,6-dihydro-
5,8-epoxy-,-caroten-6ʹ-one, 11)
1H NMR (500 MHz, CDCl3)  0.84 (3H, s, Me-16ʹ), 1.12 (3H, s Me-16)b, 1.19 (3H, s, Me-
17)b, 1.22 (3H, s Me-17ʹ), 1.38 (3H, s Me-18ʹ), 1.48 (3H, s Me-18), 1.49 (1H, dd, H ax-C4ʹ, 
Jgem=14.5 Hz, J4ʹax,3ʹ=3.1 Hz), 1.71 (1H, dd, Hax-2ʹ, Jgem = 13.7 Hz, J2ʹax,3ʹ = 3.2 Hz), 1.81 (3H, s, 
Me-19); 1.96 (3H, s, Me-19ʹ); 1.98 (6H, s, Me-20,20ʹ); 2.02 (1H, dd, Heq-2ʹ,  Jgem  = 13.7 Hz, 
J2ʹeq,3ʹ = 7.8 Hz); 2.95 (1H, dd, Heq-4ʹ, Jgem = 14.5 Hz, J4ʹeq,3ʹ = 8.7 Hz); 4.51 (1H, m, H-3ʹ); 5.07 
(1H, br. s, H-8, J7,8 ~ 1.7 Hz); 5.24 (1H, d, H-7); 6.19 (1H, d, H-10, J10,11 = 11.2 Hz), 6.23 (1H, 
d, H-14, J14,15  = 11.4 Hz); 6.32 (1H, d, H-12); 6.34 (1H, d, H-14ʹ); 6.46 (1H, d, H-7ʹ,  J7ʹ,8ʹ  = 
15.1 Hz), 6.51 (1H, dd, H-11, J11,10 = 15.0 Hz); 6.53 (1H, d, H-12ʹ, J12ʹ,11ʹ = 14.6 Hz), 6.57 (1H, 
d, H-10ʹ,  J10ʹ,11ʹ  = 11.2 Hz); 6.62 (1H, dd, H-11ʹ); 6.64 (1H, m, H-15); 6.70 (1H, m, H-15ʹ); 
7.32 (1H, d, H-8ʹ,  J8ʹ,7ʹ  = 15.1 Hz); 13C NMR (125 MHz, CDCl3):  12.5 (C-19); 12.9 (C-
20ʹ)a; 13.0 (C-19ʹ,20)b; 20.3 (C-3); 21.3 (C-18ʹ); 25.1 (C-17ʹ); 25.8 (C-16); 25.9 (C-16ʹ); 25.9 
(C-18); 30.6 (C-17); 41.2 (C-4); 41.4 (C-2); 45.3 (C-4ʹ); 50.9 (C-2ʹ); 70.4 (C-3ʹ); 87.7 (C-8); 
117.6 (C-7); 120.9 (C-7ʹ), 124.2 (C-11ʹ), 126.8 (C-10); 131.7 (C-15ʹ), 134.9 (C-14ʹ), 140.7 (C-
10ʹ), 141.9 (C-12ʹ), 146.8 (C8ʹ). HPLC-ECD n-hexane/EtOH 8:2,  [nm] (): 376 (0.87), 
330 (2.82), 321sh (2.63), 282sh (0.68), 267 (3.73), 229sh (2.55), 204 (12.22).
(5R,8R,3ʹS,5ʹR)-Cryptocapsin-5,8-epoxide ((5R,8R,3ʹS,5ʹR)-3ʹ-hydroxy-5,6-dihydro-
5,8-epoxy-,-caroten-6ʹ-one, 12)
1H NMR (500 MHz, CDCl3)  0.84 (3H, s, Me-16ʹ), 1.11 (3H, s, Me-16)a, 1.16 (3H, s, Me-
17)a, 1.22 (3H, s, Me-17ʹ); 1.25 (1H, m, Hax-2); 1.38 (3H, s, Me-18ʹ), 1.44 (3H, s, Me-18), 
1.49 (1H, dd, Hax-4ʹ, Jgem = 14.5 Hz, J4ʹax,3ʹ = 3.1 Hz), 1.59 (1H, m, Heq-2); 1.61 (1H, m, Hax-4); 
1.65 (1H, m, H-3); 1.71 (1H, dd, Hax-2ʹ, Jgem = 13.6 Hz); 1.76 (3H, s, Me-19); 1.96 (3H, s, Me-
19ʹ); 1.98 (6H, s, Me- 20,20ʹ); 2.01 (1H, m, Heq-4); 2.02 (1H, dd, Heq-2ʹ, J2ʹeq,3ʹ = 8.1 Hz); 2.95 
(1H, dd, Heq-4ʹ, J4ʹeq,3ʹ = 8.5 Hz); 4.51 (1H, m, H-3ʹ); 5.16 (1H, d, H-7, J7,8<1 Hz); 5.18 (1H, d, 
H-8); 6.20 (1H, d, H-10, J10,11 = 11.4 Hz); 6.23 (1H, d, H-14, J14,15 = 11.4 Hz); 6.32 (1H, d, H-
12, J12,11 = 15 Hz), 6.34 (1H, d, H-14ʹ); 6.46 (1H, d, H-7ʹ, J7ʹ,8ʹ = 15.1 Hz); 6.51 (1H, dd, H-11, 
J11,10 = 15.0 Hz); 6.53 (1H, dd, H-12ʹ, J12ʹ,11ʹ  = 14.6 Hz); 6.57 (1H, d, H-10ʹ, J10ʹ,11ʹ  = 11.4 Hz); 
6.62 (1H, dd, H-11ʹ); 6.64 (1H, m, H-15); 6.70 (1H, m, H-15ʹ); 7.32 (1H, d, H-8ʹ, J8ʹ,7ʹ = 15.1 
Hz); 13C NMR (125 MHz, CDCl3): 12.5 (C-19); 12.9 (C-20ʹ)
a; 13.0 (C-19ʹ, 20)b; 20.3 (C-
3); 21.3 (C-18ʹ); 25.1 (C-17ʹ); 25.8 (C-16); 25.9 (C-16ʹ); 25.9 (C-18); 30.6 (C-17); 41.2 (C-4); 
41.4 (C-2); 45.3 (C-4ʹ); 50.9 (C-2ʹ); 70.4 (C-3ʹ); 87.1 (C-8); 118.7 (C-7); 120.9 (C-7ʹ); 124.2 
(C-11ʹ); 126.8 (C-10); 131.6 (C-15ʹ); 134.9 (C-14ʹ); 140.7 (C-10ʹ); 141.9 (C-12ʹ); 146.8 (C-
8ʹ). HPLC-ECD n-hexane/EtOH 8:2,  [nm] (): 395 (0.13), 373sh (0.68), 348 (1.29), 
265 (7.73), 234sh (3.14), 205 (18.85).
(5S,8R,3ʹS,5ʹR)-Cryptocapsin-5,8-epoxide ((5S,8R,3ʹS,5ʹR)-3ʹ-hydroxy-5,6-dihydro-
5,8-epoxy-,-caroten-6ʹ-one, 13)
tr= 15.8 min on Chiralcel IC (5 µm, 150  4.6 mm) with n-hexane/EtOH 8:2 and a flow rate of 
1.0 mL/min.  HPLC-ECD n-hexane/EtOH 8:2,   [nm] (): 391 (0.21), 367sh (0.30), 354 
(0.41), 325 (0.61), 265sh (2.36), 258 (2.37), 234sh (1.79), 205 (7.98).
(5S,8S,3ʹS,5ʹR)-Cryptocapsin-5,8-epoxide ((5S,8S,3ʹS,5ʹR)-3ʹ-hydroxy-5,6-dihydro-
5,8-epoxy-,-caroten-6ʹ-one, 14)
tr= 17.2 min on Chiralcel IC (5 µm, 150  4.6 mm) with n-hexane/EtOH 8:2 and a flow rate of 
1.0 mL/min.  HPLC-ECD n-hexane/EtOH 8:2,   [nm] (): 364 (0.85), 331 (5.35), 321sh 
(4.78), 306sh (2.12), 284sh (0.58), 267 (7.54), 233sh (2.24), 204 (18.44).
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Figure 1. ECD spectra of (5R,6S,3ʹS,5ʹR)-cryptocapsin-5,6-epoxide (5, red) (3R,5R,6S,5ʹR)-
3ʹ-deoxycapsanthin-5,6-epoxide  (6,  blue)  and  (3S,5R,6S,5ʹR,6ʹS)--cryptoxanthin-5,6,5ʹ,6ʹ-
diepoxide (8, black).
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Figure 2. a) HPLC-UV (upper blue curve) and -OR (lower red curve) chromatograms of the 
separated (5R,6S,3ʹS,5ʹR)- and (5S,6R,3ʹS,5ʹR)-cryptocapsin-5,6-epoxide diastereomers (5, 7) 
monitored at 480 nm (Chiralcel OD, n-hexane/EtOH 50:50). b) HPLC-ECD (upper blue 
curve) and –UV (lower red curve) chromatograms of the separated (5R,6S,3ʹS,5ʹR)- and 
(5S,6R,3ʹS,5ʹR)-cryptocapsin-5,6-epoxide diastereomers monitored at 280 nm with J-810 
spectropolarimeter (Chiralcel OD, n-hexane/EtOH 50:50).
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Figure  3. HPLC-ECD  spectra  of  (5R,6S,3ʹS,5ʹR)–cryptocapsin-5,6-epoxide  (5,  red,  first-
eluting  distereomer)  and  (5S,6R,3ʹS,5ʹR)-cryptocapsin-5,6-epoxide  (7,  blue,  second-eluting 
diastereomer).
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Figure 4. Overlapped HPLC-UV traces (463 nm) of natural [blue, (5R,8S,3ʹS,5ʹR)-11, 
(5R,8R,3ʹS,5ʹR)-12] and semisynthetic stereoisomeric  mixture of cryptocapsin-5,8-
epoxides [red, (5R,8S,3ʹS,5ʹR)-11, (5R,8R,3ʹS,5ʹR)-12, (5S,8R,3ʹS,5ʹR)-13, (5S,8S,3ʹS,5ʹR)-
14] with Chiralpak IC column (n-hexane/EtOH 80:20); 
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Figure 5. HPLC-ECD spectra of diastereomeric cryptocapsin-5,8-epoxides in n-
hexane/EtOH 80:20: black: (5R8S,3ʹS,5ʹR)-11, first-eluting; red: (5S8S,3ʹS,5ʹR)-14, 
second-eluting; blue: (5S8R,3ʹS,5ʹR)-13, third-eluting; brown: (5R8R,3ʹS,5ʹR)-12, fourth-
eluting diastereomer.
Schemes:
HO
ß-Cryptoxanthin-5,6,5',6'-diepoxide
O
O
O
OH
Cryptocapsin-5,6-epoxide
O
O
3'-Deoxycapsanthin-5,6-epoxide
O
HO
Scheme. 1. Formation of cryptocapsin-5,6-epoxide (5) and 3ʹ-deoxycapsanthin-5,6-epoxide 
(6) from -cryptoxanthin-5,6,5ʹ,6ʹ-diepoxide (8)
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